LU81300A1 - Derives d'hydantoine,procede pour leur preparation et application de ces composes comme medicaments - Google Patents

Derives d'hydantoine,procede pour leur preparation et application de ces composes comme medicaments Download PDF

Info

Publication number
LU81300A1
LU81300A1 LU81300A LU81300A LU81300A1 LU 81300 A1 LU81300 A1 LU 81300A1 LU 81300 A LU81300 A LU 81300A LU 81300 A LU81300 A LU 81300A LU 81300 A1 LU81300 A1 LU 81300A1
Authority
LU
Luxembourg
Prior art keywords
group
formula
compound
butyl
hydantoin
Prior art date
Application number
LU81300A
Other languages
English (en)
French (fr)
Inventor
W Ross
W Jamieson
R Simmonds
J Verge
Original Assignee
Lilly Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Industries Ltd filed Critical Lilly Industries Ltd
Publication of LU81300A1 publication Critical patent/LU81300A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/96—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72—Two oxygen atoms, e.g. hydantoin
    • C07D233/74—Two oxygen atoms, e.g. hydantoin with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to other ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72—Two oxygen atoms, e.g. hydantoin
    • C07D233/76—Two oxygen atoms, e.g. hydantoin with substituted hydrocarbon radicals attached to the third ring carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72—Two oxygen atoms, e.g. hydantoin
    • C07D233/76—Two oxygen atoms, e.g. hydantoin with substituted hydrocarbon radicals attached to the third ring carbon atom
    • C07D233/78—Radicals substituted by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pulmonology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
LU81300A 1978-05-23 1979-05-22 Derives d'hydantoine,procede pour leur preparation et application de ces composes comme medicaments LU81300A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB2135278 1978-05-23
GB21352/78A GB1601310A (en) 1978-05-23 1978-05-23 Aryl hydantoins

Publications (1)

Publication Number Publication Date
LU81300A1 true LU81300A1 (fr) 1980-12-16

Family

ID=10161451

Family Applications (1)

Application Number Title Priority Date Filing Date
LU81300A LU81300A1 (fr) 1978-05-23 1979-05-22 Derives d'hydantoine,procede pour leur preparation et application de ces composes comme medicaments

Country Status (31)

Country Link
US (2) US4241073A (pl)
EP (1) EP0005647B1 (pl)
JP (1) JPS54160373A (pl)
KR (1) KR830000635B1 (pl)
AR (2) AR225143A1 (pl)
AT (1) AT366034B (pl)
AU (1) AU530968B2 (pl)
BE (1) BE876435A (pl)
BG (2) BG31799A3 (pl)
CA (1) CA1120481A (pl)
CH (2) CH639650A5 (pl)
CS (2) CS208654B2 (pl)
DD (1) DD143769A5 (pl)
DE (1) DE2963061D1 (pl)
DK (1) DK207579A (pl)
ES (1) ES480850A1 (pl)
FI (1) FI791614A (pl)
FR (1) FR2426681A1 (pl)
GB (1) GB1601310A (pl)
GR (1) GR68363B (pl)
HU (1) HU184648B (pl)
IL (1) IL57343A (pl)
LU (1) LU81300A1 (pl)
MX (1) MX5604E (pl)
NZ (1) NZ190512A (pl)
PL (2) PL119612B1 (pl)
PT (1) PT69648A (pl)
RO (2) RO79703A (pl)
SU (2) SU873878A3 (pl)
YU (1) YU120179A (pl)
ZA (1) ZA792501B (pl)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3013647C2 (de) * 1980-04-09 1985-07-11 Degussa Ag, 6000 Frankfurt Verfahren zur Herstellung von 5-Arylidenhydantoinen (B)
US4431656A (en) * 1981-02-05 1984-02-14 Kanegafuchi Chemical Industry Company Limited 3,5-di-Tert-butylstyrene derivatives, salts thereof, and pharmaceutical compositions containing the same as an active ingredient
US4684735A (en) * 1985-07-01 1987-08-04 Stauffer Chemical Company Promotion of raney nickel hydrogenation catalyst
JPS6317864A (ja) * 1986-07-11 1988-01-25 Mitsui Toatsu Chem Inc ヒダントイン類の製造方法
NL8800099A (nl) * 1987-01-31 1988-08-16 Sandoz Ag Pilocarpinederivaten en werkwijzen voor het bereiden en toepassen van deze derivaten.
IE940525L (en) * 1988-05-25 1989-11-25 Warner Lambert Co Known and selected novel arylmethylenyl derivatives of¹thiazolidinones, imidazolidinones and oxazolidinones useful¹as antiallergy agents and antiinflammatory agents
US5143928A (en) * 1990-03-27 1992-09-01 Warner-Lambert Company 3,5-di-tertiarybutyl-4-hydroxyphenylmethylene derivatives of 2-substituted thiazolidinones, oxazolidinones, and imidazolidinones as antiinflammatory agents
ATE146462T1 (de) * 1990-04-27 1997-01-15 Orion Yhtymae Oy Pharmakologisch aktive catecholderivate
FR2687153B1 (fr) * 1992-02-07 1994-05-13 Hoechst Ste Francaise Procede de preparation de la (thenyl-2)-5 hydantouine.
WO1995029910A1 (en) * 1994-04-28 1995-11-09 Yamanouchi Pharmaceutical Co., Ltd. Imidazolidinedione derivative
SE0100903D0 (sv) * 2001-03-15 2001-03-15 Astrazeneca Ab Compounds
SE0100902D0 (sv) * 2001-03-15 2001-03-15 Astrazeneca Ab Compounds
SE0103710D0 (sv) * 2001-11-07 2001-11-07 Astrazeneca Ab Compounds
EA007163B1 (ru) * 2001-11-30 2006-08-25 Эли Лилли Энд Компани Агонисты рецепторов, активируемых пероксисомным пролифератором
SE0202539D0 (sv) * 2002-08-27 2002-08-27 Astrazeneca Ab Compounds
GB0221246D0 (en) * 2002-09-13 2002-10-23 Astrazeneca Ab Compounds
FR2845000B1 (fr) * 2002-09-27 2005-05-27 Oreal Utilisation d'un compose heterocyclique ou de l'un de ses sels pour stimuler ou induire la pousse des cheveux et/ou freiner leur chute
US7648992B2 (en) 2004-07-05 2010-01-19 Astrazeneca Ab Hydantoin derivatives for the treatment of obstructive airway diseases
SE0401762D0 (sv) * 2004-07-05 2004-07-05 Astrazeneca Ab Novel compounds
SE0403086D0 (sv) * 2004-12-17 2004-12-17 Astrazeneca Ab Compounds
SE0403085D0 (sv) * 2004-12-17 2004-12-17 Astrazeneca Ab Novel componds
TW200831488A (en) * 2006-11-29 2008-08-01 Astrazeneca Ab Novel compounds
ES2542153T3 (es) * 2007-05-30 2015-07-31 F. Hoffmann-La Roche Ag Inhibidores no nucleósidos de la transcriptasa inversa
CN101990534A (zh) * 2007-11-01 2011-03-23 Uab研究基金会 治疗和预防病毒感染
GB2463514C (en) * 2008-09-11 2018-09-26 Galapagos Nv Imidazolidine compounds and uses therefor
ITBO20090078A1 (it) * 2009-02-13 2010-08-14 Consiglio Nazionale Ricerche Composti per il trattamento del tumore alla prostata e procedimenti per la loro sintesi

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR910275A (fr) * 1944-11-14 1946-06-03 Nouvelles hydantoïnes et leur procédé de préparation
US2479065A (en) * 1945-09-06 1949-08-16 Du Pont Preparation of 5-benzylhydantoin
US2861079A (en) * 1956-06-04 1958-11-18 Dow Chemical Co Process for making unsaturated hydantoins
GB846601A (en) * 1958-01-13 1960-08-31 British Oxygen Res And Dev Ltd Vinyl hydantoins
NL131665C (pl) * 1964-05-18
US3395153A (en) * 1964-12-16 1968-07-30 United States Borax Chem 3, 5-dialkylhydantoins
US3847933A (en) * 1970-12-09 1974-11-12 Exxon Research Engineering Co Acid catalyzed alkylation of hydantoin
JPS5136332B1 (pl) * 1970-12-09 1976-10-07
US3932449A (en) * 1973-10-09 1976-01-13 Morton-Norwich Products, Inc. 5-(P-dimethylaminobenzyl) hydantoin
GB1575904A (en) * 1976-04-23 1980-10-01 Lilly Industries Ltd Phenyl piperazines
JPS54122276A (en) * 1978-03-15 1979-09-21 Kanegafuchi Chem Ind Co Ltd Preparation of 5-(2-thienyl) hydantion

Also Published As

Publication number Publication date
AU4728979A (en) 1979-11-29
GR68363B (pl) 1981-12-23
AR225143A1 (es) 1982-02-26
ES480850A1 (es) 1980-02-01
US4293563A (en) 1981-10-06
RO79703A (ro) 1982-08-17
CH639650A5 (fr) 1983-11-30
FR2426681B1 (pl) 1983-08-12
CS208653B2 (en) 1981-09-15
DD143769A5 (de) 1980-09-10
EP0005647A1 (en) 1979-11-28
JPS54160373A (en) 1979-12-19
AU530968B2 (en) 1983-08-04
BG32115A4 (en) 1982-05-14
DE2963061D1 (en) 1982-07-29
US4241073A (en) 1980-12-23
FR2426681A1 (fr) 1979-12-21
PT69648A (en) 1979-06-01
NZ190512A (en) 1984-10-19
HU184648B (en) 1984-09-28
YU120179A (en) 1983-02-28
PL125075B1 (en) 1983-03-31
IL57343A (en) 1982-09-30
CA1120481A (en) 1982-03-23
ZA792501B (en) 1980-05-28
BE876435A (fr) 1979-11-21
SU873878A3 (ru) 1981-10-15
RO76807A (ro) 1981-04-26
CH643546A5 (fr) 1984-06-15
PL222701A1 (pl) 1980-12-15
EP0005647B1 (en) 1982-06-09
PL119612B1 (en) 1982-01-30
IL57343A0 (en) 1979-09-30
FI791614A (fi) 1979-11-24
MX5604E (es) 1983-11-07
DK207579A (da) 1979-11-24
AR224186A1 (es) 1981-10-30
KR830000635B1 (ko) 1983-03-23
BG31799A3 (en) 1982-03-15
CS208654B2 (en) 1981-09-15
PL215773A1 (pl) 1980-07-14
ATA373379A (de) 1981-07-15
AT366034B (de) 1982-03-10
GB1601310A (en) 1981-10-28
SU988190A3 (ru) 1983-01-07

Similar Documents

Publication Publication Date Title
LU81300A1 (fr) Derives d'hydantoine,procede pour leur preparation et application de ces composes comme medicaments
FR2665444A1 (fr) Derives d'amino-benzofuranne, benzothiophene ou indole, leur procede de preparation ainsi que les compositions les contenant.
LU81613A1 (fr) Nouvelles spiro-oxazolidine-diones
CA2267154A1 (fr) Derives d'aminothiazole, leur procede de preparation et les compositions pharmaceutiques les contenant
CH640837A5 (fr) Derives de l'imidazole.
US5110831A (en) Vinylogous hydroxamic acids and derivatives thereof as 5-lipoxygenase inhibitors
CH646967A5 (fr) Composes de pyranone et compositions pharmaceutiques les comprenant.
EP0041410B1 (fr) Nouveaux éthers tricycliques, leurs procédés de préparation et leur utilisation comme médicament
EP0566446B1 (fr) Dérivés d'indane-1, 3-dione et d'indane-1,2,3-trione, leurs procédés de préparation et leur application en thérapeutique
CH646687A5 (fr) Derives de l'acide cyclohexane carboxylique.
FR2685329A1 (fr) Derives de 3(2h)-pyridazinone et procede pour les preparer.
CA2021250A1 (fr) Medicaments a base de derives de 1h-benzoxadiazine-4, 1, 2, nouveaux derives et leurs procedes de preparation
BE1004995A3 (fr) Nouveau derive de 5h-benzodiazepine, compositions pharmaceutiques le contenant et procede pour les preparer.
EP0418933A1 (fr) Dérivés d'alcadiènes, leurs préparations, les médicaments les contenant et produits intermédiaires
LU81676A1 (fr) Nouveaux derives d'aurones,leur procede de preparation et leur utilisation comme produits pharmaceutiques
EP0133176B1 (fr) Composition pharmaceutique ou vétérinaire destinée à combattre des troubles ischémiques cardiaques
CA1139763A (fr) Procede d'obtention de nouveaux aryltrifluoroethanols
BE884387A (fr) Composition a base d'acides aryloxyalkylaminobenzoiques, leurs sels et leurs esters
CA1076117A (fr) Procede d'obtention de nouveaux ethers aryliques et les produits en resultant
EP0534856B1 (fr) Ethers d'oximes de thiénocyclopentanones, leur préparation et compositions pharmaceutiques les contenant
FR2692894A1 (fr) Aryl-1-(o-alcoxy-phényl-4-pipérazinyl-1)-2, 3- ou 4-alcanols, leur procédé de préparation et leur utilisation pour la préparation de médicaments.
FR2524881A1 (fr) Nouvelles indole-alkylene-amines substituees, leur preparation et leur utilisation comme medicaments
CH627750A5 (fr) Derives de la benzophenone, procede de preparation et compositions pharmaceutiques.
FR2464251A1 (fr) Nouvelles 4-(4-cinnamoyl-1-piperidino)butyrophenones, utiles notamment comme agents antipsychotiques, et leur procede de preparation
BE849323A (fr) Derives nouveaux d'alcool benzylique et procedes pour leur preparation